Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 4.35 billion. The enterprise value is 6.09 billion.
| Market Cap | 4.35B |
| Enterprise Value | 6.09B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.74% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 2,102.28 and the forward PE ratio is 42.00.
| PE Ratio | 2,102.28 |
| Forward PE | 42.00 |
| PS Ratio | 1.45 |
| PB Ratio | 8.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.16, with an EV/FCF ratio of -201.50.
| EV / Earnings | 2,942.63 |
| EV / Sales | 2.04 |
| EV / EBITDA | 14.16 |
| EV / EBIT | 40.92 |
| EV / FCF | -201.50 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 3.74.
| Current Ratio | 0.78 |
| Quick Ratio | 0.54 |
| Debt / Equity | 3.74 |
| Debt / EBITDA | 4.24 |
| Debt / FCF | -60.40 |
| Interest Coverage | 1.62 |
Financial Efficiency
Return on equity (ROE) is -2.32% and return on invested capital (ROIC) is 4.21%.
| Return on Equity (ROE) | -2.32% |
| Return on Assets (ROA) | 3.16% |
| Return on Invested Capital (ROIC) | 4.21% |
| Return on Capital Employed (ROCE) | 6.67% |
| Revenue Per Employee | 465,921 |
| Profits Per Employee | 322 |
| Employee Count | 6,638 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 11.48 |
Taxes
In the past 12 months, Med Life has paid 22.59 million in taxes.
| Income Tax | 22.59M |
| Effective Tax Rate | 205.17% |
Stock Price Statistics
The stock price has increased by +36.50% in the last 52 weeks. The beta is 0.61, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +36.50% |
| 50-Day Moving Average | 7.89 |
| 200-Day Moving Average | 6.80 |
| Relative Strength Index (RSI) | 62.23 |
| Average Volume (20 Days) | 155,956 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 2.99 billion and earned 2.07 million in profits. Earnings per share was 0.00.
| Revenue | 2.99B |
| Gross Profit | 1.45B |
| Operating Income | 148.69M |
| Pretax Income | 11.01M |
| Net Income | 2.07M |
| EBITDA | 338.60M |
| EBIT | 148.69M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 149.56 million in cash and 1.82 billion in debt, giving a net cash position of -1.67 billion or -3.15 per share.
| Cash & Cash Equivalents | 149.56M |
| Total Debt | 1.82B |
| Net Cash | -1.67B |
| Net Cash Per Share | -3.15 |
| Equity (Book Value) | 488.30M |
| Book Value Per Share | 0.80 |
| Working Capital | -188.64M |
Cash Flow
In the last 12 months, operating cash flow was 215.41 million and capital expenditures -245.61 million, giving a free cash flow of -30.20 million.
| Operating Cash Flow | 215.41M |
| Capital Expenditures | -245.61M |
| Free Cash Flow | -30.20M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 48.60%, with operating and profit margins of 4.98% and 0.07%.
| Gross Margin | 48.60% |
| Operating Margin | 4.98% |
| Pretax Margin | 0.37% |
| Profit Margin | 0.07% |
| EBITDA Margin | 11.33% |
| EBIT Margin | 4.98% |
| FCF Margin | n/a |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 0.05% |
| FCF Yield | -0.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 6 |